PharmiWeb1d
Direct-to-consumer Genetic DNA Tests Market Forecast: 12.1% CAGR to Drive Growth to US$ 5.3 Billion by 2032 – Analysis by VMR
Direct-to-consumer Genetic DNA Tests Market Size and ForecastThe Direct-to-consumer (DTC) genetic DNA testing market has ...
PharmiWeb18d
Diastolic Heart Failure Drug Market Analysis (2024-2034)
Major companies profiled in Diastolic Heart Failure Drug Market are:- Novartis,Pfizer,AstraZeneca,Merck & Co.,Johnson & Johnson,Bristol-Myers Squibb,Sanofi,GlaxoSmithKline ... competing scenario along ...
US Transthyretin Amyloidosis Treatment Market Rising Growth Due To Advancements In Rare Disease Therapies With CAGR 9.6%
US Transthyretin Amyloidosis Treatment Market Growth BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire / -- The U.S. transthyretin a ...
GitHub21d
Singapore Substance Abuse Treatment Market By Type, Applications, Beneficial Analysis and Key Vendors - GSK, Alkermes, Pfizer, Allergan.md
Contribute to rutuja456/Report-Analysis development by creating an account on GitHub. Skip to content Navigation Menu Toggle navigation Sign in ...
GitHub22d
Singapore Kidney Cancer Drugs Market By Type, Applications, Beneficial Analysis and Key Vendors - GlaxoSmithKline, Bayer, Novartis, Roche.md
Contribute to rutuja456/Report-Analysis development by creating an account on GitHub. Skip to content Navigation Menu Toggle navigation Sign in ...
BioSpace2d
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...
GSK studying if best-selling shingles vaccine lowers dementia risk
GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...
Looking Into GSK's Recent Short Interest
According to Benzinga Pro, GSK's peer group average for short interest as a percentage of float is 4.22%, which means the company has less short interest than most of its peers. Did you know that ...
Jim Cramer Says ‘Buy and Put Away’ GSK (GSK) for Its 4% Yield
GSK plc (NYSE:GSK) is engaged in research, development, and production of vaccines, as well as specialized and general medicines aimed at preventing and treating various diseases. In early March, ...
Dechert to Defend GSK in Securities Class Action Over Alleged Link Between Zantac and Carcinogenic Compound
This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state and federal courts. Click here to get started and be first to act on ...